Table 3.
Comparison of prevalence of variant alleles estimated by chi-square analyses in subgroups
| Wild Type Homozygotes n (%) |
Variant-Allele Carriers n (%) |
p valuea | |
|---|---|---|---|
| ALT ≥ 40 (U/L) | 54 (40.6) | 79 (59.4) | 0.918 |
| ALT < 40 (U/L) | 145 (41.4) | 205 (58.6) | |
| 75th HOMA-IR (U) | 48 (36.6) | 83 (63.4) | 0.512 |
| 25th HOMA-IR (U) | 55 (41.4) | 78 (58.6) | |
| Liver steatosis | 49 (42.6) | 66 (57.4) | 0.869 |
| No liver steatosis | 25 (45.5) | 30 (54.5) | |
a P values were calculated using the Pearson χ2. Abbreviations: ALT, alanine transaminase; HOMA-IR, homeostatic model assessment of insulin resistance.